|
|
 |
 |
|  |  |
 |  |  |  |  |
organism-gene
 |


|
 PR:P51587 |
   breast cancer type 2 susceptibility protein (human)
 |
   hBRCA2
 |
  "A breast cancer type 2 susceptibility protein that is encoded in the genome of human." [PRO:DNx]
 |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060274 |
   breast cancer type 2 susceptibility protein sequence variant Q1998* (human)
 |
   hBRCA2/var:Q1998*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Arg-1997 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1997." [PRO:DNx, Reactome:R-HSA-9711269]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060282 |
   breast cancer type 2 susceptibility protein sequence variant L1740* (human)
 |
   hBRCA2/var:L1740*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-1739 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1739." [PRO:DNx, Reactome:R-HSA-9711136]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060285 |
   breast cancer type 2 susceptibility protein sequence variant S1968* (human)
 |
   hBRCA2/var:S1968*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1967 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1967." [PRO:DNx, Reactome:R-HSA-9711572]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060333 |
   breast cancer type 2 susceptibility protein sequence variant Q3066* (human)
 |
   hBRCA2/var:Q3066*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Phe-3065 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3065." [PRO:DNx, Reactome:R-HSA-9711152]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060343 |
   breast cancer type 2 susceptibility protein sequence variant Y1762* (human)
 |
   hBRCA2/var:Y1762*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-1761 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1761." [PRO:DNx, Reactome:R-HSA-9711465]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060354 |
   breast cancer type 2 susceptibility protein sequence variant G1529E (human)
 |
   hBRCA2/var:G1529E
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Glu residue at the position equivalent to Gly-1529 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Gly-1529, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9709597]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060390 |
   breast cancer type 2 susceptibility protein sequence variant S3245* (human)
 |
   hBRCA2/var:S3245*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-3244 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3244." [PRO:DNx, Reactome:R-HSA-9711234]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060393 |
   breast cancer type 2 susceptibility protein sequence variant E2906* (human)
 |
   hBRCA2/var:E2906*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-2905 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2905." [PRO:DNx, Reactome:R-HSA-9711164]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060421 |
   breast cancer type 2 susceptibility protein sequence variant L2362* (human)
 |
   hBRCA2/var:L2362*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to His-2361 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2361." [PRO:DNx, Reactome:R-HSA-9711365]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060427 |
   breast cancer type 2 susceptibility protein sequence variant E1120* (human)
 |
   hBRCA2/var:E1120*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-1119 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1119." [PRO:DNx, Reactome:R-HSA-9711367]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060466 |
   breast cancer type 2 susceptibility protein sequence variant E3053* (human)
 |
   hBRCA2/var:E3053*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Arg-3052 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3052." [PRO:DNx, Reactome:R-HSA-9711318]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060489 |
   breast cancer type 2 susceptibility protein sequence variant K1860* (human)
 |
   hBRCA2/var:K1860*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-1859 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1859." [PRO:DNx, Reactome:R-HSA-9711580]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060516 |
   breast cancer type 2 susceptibility protein sequence variant E865* (human)
 |
   hBRCA2/var:E865*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gln-864 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-864." [PRO:DNx, Reactome:R-HSA-9711272]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060539 |
   breast cancer type 2 susceptibility protein sequence variant G934* (human)
 |
   hBRCA2/var:G934*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Thr-933 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-933." [PRO:DNx, Reactome:R-HSA-9712147]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060549 |
   breast cancer type 2 susceptibility protein sequence variant E2028* (human)
 |
   hBRCA2/var:E2028*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Arg-2027 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2027." [PRO:DNx, Reactome:R-HSA-9711557]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060568 |
   breast cancer type 2 susceptibility protein sequence variant Q2823* (human)
 |
   hBRCA2/var:Q2823*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-2822 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2822." [PRO:DNx, Reactome:R-HSA-9711553]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060571 |
   breast cancer type 2 susceptibility protein sequence variant E97* (human)
 |
   hBRCA2/var:E97*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-96 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-96." [PRO:DNx, Reactome:R-HSA-9711290]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060575 |
   breast cancer type 2 susceptibility protein sequence variant L557* (human)
 |
   hBRCA2/var:L557*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-556 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-556." [PRO:DNx, Reactome:R-HSA-9712154]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060602 |
   breast cancer type 2 susceptibility protein sequence variant S2994* (human)
 |
   hBRCA2/var:S2994*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-2993 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2993." [PRO:DNx, Reactome:R-HSA-9711423]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060630 |
   breast cancer type 2 susceptibility protein sequence variant Y803* (human)
 |
   hBRCA2/var:Y803*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-802 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-802." [PRO:DNx, Reactome:R-HSA-9711267]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060653 |
   breast cancer type 2 susceptibility protein sequence variant Q1562* (human)
 |
   hBRCA2/var:Q1562*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to His-1561 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1561." [PRO:DNx, Reactome:R-HSA-9711346]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060654 |
   breast cancer type 2 susceptibility protein sequence variant S2095* (human)
 |
   hBRCA2/var:S2095*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-2094 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2094." [PRO:DNx, Reactome:R-HSA-9711158]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060677 |
   breast cancer type 2 susceptibility protein sequence variant Y3006* (human)
 |
   hBRCA2/var:Y3006*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Arg-3005 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3005." [PRO:DNx, Reactome:R-HSA-9711222]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060692 |
   breast cancer type 2 susceptibility protein sequence variant L1208* (human)
 |
   hBRCA2/var:L1208*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-1207 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1207." [PRO:DNx, Reactome:R-HSA-9711575]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060763 |
   breast cancer type 2 susceptibility protein sequence variant C711* (human)
 |
   hBRCA2/var:C711*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-710 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-710." [PRO:DNx, Reactome:R-HSA-9711577]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060791 |
   breast cancer type 2 susceptibility protein sequence variant C2422* (human)
 |
   hBRCA2/var:C2422*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gln-2421 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2421." [PRO:DNx, Reactome:R-HSA-9711246]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060829 |
   breast cancer type 2 susceptibility protein sequence variant K2555* (human)
 |
   hBRCA2/var:K2555*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-2554 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2554." [PRO:DNx, Reactome:R-HSA-9711337]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060858 |
   breast cancer type 2 susceptibility protein sequence variant S871* (human)
 |
   hBRCA2/var:S871*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-870 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-870." [PRO:DNx, Reactome:R-HSA-9711227]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060887 |
   breast cancer type 2 susceptibility protein sequence variant S1442* (human)
 |
   hBRCA2/var:S1442*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-1441 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1441." [PRO:DNx, Reactome:R-HSA-9711404]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060891 |
   breast cancer type 2 susceptibility protein sequence variant W2626C (human)
 |
   hBRCA2/var:W2626C
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Cys residue at the position equivalent to Trp-2626 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Trp-2626, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9763223]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060946 |
   breast cancer type 2 susceptibility protein sequence variant Q499* (human)
 |
   hBRCA2/var:Q499*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Phe-498 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-498." [PRO:DNx, Reactome:R-HSA-9711555]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060956 |
   breast cancer type 2 susceptibility protein sequence variant I2627F (human)
 |
   hBRCA2/var:I2627F
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Phe residue at the position equivalent to Ile-2627 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Ile-2627, CHEBI:29997." [PRO:DNx, Reactome:R-HSA-9763218]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000060984 |
   breast cancer type 2 susceptibility protein sequence variant S1013* (human)
 |
   hBRCA2/var:S1013*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ala-1012 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1012." [PRO:DNx, Reactome:R-HSA-9711313]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061047 |
   breast cancer type 2 susceptibility protein sequence variant E1514* (human)
 |
   hBRCA2/var:E1514*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-1513 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1513." [PRO:DNx, Reactome:R-HSA-9711527]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061049 |
   breast cancer type 2 susceptibility protein sequence variant W2970* (human)
 |
   hBRCA2/var:W2970*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-2969 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2969." [PRO:DNx, Reactome:R-HSA-9711248]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061057 |
   breast cancer type 2 susceptibility protein sequence variant E2847* (human)
 |
   hBRCA2/var:E2847*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-2846 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2846." [PRO:DNx, Reactome:R-HSA-9712152]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061074 |
   breast cancer type 2 susceptibility protein sequence variant Y1714* (human)
 |
   hBRCA2/var:Y1714*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-1713 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1713." [PRO:DNx, Reactome:R-HSA-9711344]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061081 |
   breast cancer type 2 susceptibility protein sequence variant S1720* (human)
 |
   hBRCA2/var:S1720*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-1719 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1719." [PRO:DNx, Reactome:R-HSA-9711584]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061209 |
   breast cancer type 2 susceptibility protein sequence variant E808* (human)
 |
   hBRCA2/var:E808*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-807 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-807." [PRO:DNx, Reactome:R-HSA-9711405]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061227 |
   breast cancer type 2 susceptibility protein sequence variant S1064* (human)
 |
   hBRCA2/var:S1064*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gln-1063 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1063." [PRO:DNx, Reactome:R-HSA-9711386]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061243 |
   breast cancer type 2 susceptibility protein sequence variant S611* (human)
 |
   hBRCA2/var:S611*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-610 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-610." [PRO:DNx, Reactome:R-HSA-9711399]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061248 |
   breast cancer type 2 susceptibility protein sequence variant E2663Q (human)
 |
   hBRCA2/var:E2663Q
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Gln residue at the position equivalent to Glu-2663 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Glu-2663, CHEBI:30011." [PRO:DNx, Reactome:R-HSA-9763263]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061249 |
   breast cancer type 2 susceptibility protein sequence variant Q1175* (human)
 |
   hBRCA2/var:Q1175*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-1174 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1174." [PRO:DNx, Reactome:R-HSA-9711483]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061260 |
   breast cancer type 2 susceptibility protein sequence variant S450* (human)
 |
   hBRCA2/var:S450*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-449 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-449." [PRO:DNx, Reactome:R-HSA-9712116]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061267 |
   breast cancer type 2 susceptibility protein sequence variant E475* (human)
 |
   hBRCA2/var:E475*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-474 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-474." [PRO:DNx, Reactome:R-HSA-9711566]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061329 |
   breast cancer type 2 susceptibility protein sequence variant S3231* (human)
 |
   hBRCA2/var:S3231*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-3230 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3230." [PRO:DNx, Reactome:R-HSA-9711458]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061343 |
   breast cancer type 2 susceptibility protein sequence variant K1515* (human)
 |
   hBRCA2/var:K1515*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-1514 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1514." [PRO:DNx, Reactome:R-HSA-9711195]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061347 |
   breast cancer type 2 susceptibility protein sequence variant W31* (human)
 |
   hBRCA2/var:W31*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-30 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-30." [PRO:DNx, Reactome:R-HSA-9711536]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061354 |
   breast cancer type 2 susceptibility protein sequence variant E1493* (human)
 |
   hBRCA2/var:E1493*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1492 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1492." [PRO:DNx, Reactome:R-HSA-9711461]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061384 |
   breast cancer type 2 susceptibility protein sequence variant M1300* (human)
 |
   hBRCA2/var:M1300*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-1299 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1299." [PRO:DNx, Reactome:R-HSA-9712141]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061413 |
   breast cancer type 2 susceptibility protein sequence variant E2872* (human)
 |
   hBRCA2/var:E2872*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-2871 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2871." [PRO:DNx, Reactome:R-HSA-9711444]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061418 |
   breast cancer type 2 susceptibility protein sequence variant Q73* (human)
 |
   hBRCA2/var:Q73*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-72 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-72." [PRO:DNx, Reactome:R-HSA-9711502]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061434 |
   breast cancer type 2 susceptibility protein sequence variant Q609* (human)
 |
   hBRCA2/var:Q609*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-608 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-608." [PRO:DNx, Reactome:R-HSA-9711358]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061436 |
   breast cancer type 2 susceptibility protein sequence variant E1688* (human)
 |
   hBRCA2/var:E1688*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-1687 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1687." [PRO:DNx, Reactome:R-HSA-9711185]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061439 |
   breast cancer type 2 susceptibility protein sequence variant S76* (human)
 |
   hBRCA2/var:S76*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ala-75 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-75." [PRO:DNx, Reactome:R-HSA-9711258]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061442 |
   breast cancer type 2 susceptibility protein sequence variant L2926* (human)
 |
   hBRCA2/var:L2926*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gln-2925 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2925." [PRO:DNx, Reactome:R-HSA-9711348]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061485 |
   breast cancer type 2 susceptibility protein sequence variant C1200* (human)
 |
   hBRCA2/var:C1200*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-1199 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1199." [PRO:DNx, Reactome:R-HSA-9712129]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061491 |
   breast cancer type 2 susceptibility protein sequence variant Y2997* (human)
 |
   hBRCA2/var:Y2997*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-2996 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2996." [PRO:DNx, Reactome:R-HSA-9711490]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061572 |
   breast cancer type 2 susceptibility protein sequence variant K230* (human)
 |
   hBRCA2/var:K230*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-229 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-229." [PRO:DNx, Reactome:R-HSA-9711578]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061616 |
   breast cancer type 2 susceptibility protein sequence variant Q893* (human)
 |
   hBRCA2/var:Q893*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Phe-892 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-892." [PRO:DNx, Reactome:R-HSA-9711286]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061622 |
   breast cancer type 2 susceptibility protein sequence variant K3015* (human)
 |
   hBRCA2/var:K3015*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-3014 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3014." [PRO:DNx, Reactome:R-HSA-9711397]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061675 |
   breast cancer type 2 susceptibility protein sequence variant S2052* (human)
 |
   hBRCA2/var:S2052*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-2051 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2051." [PRO:DNx, Reactome:R-HSA-9711134]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061755 |
   breast cancer type 2 susceptibility protein sequence variant K1082* (human)
 |
   hBRCA2/var:K1082*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Cys-1081 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1081." [PRO:DNx, Reactome:R-HSA-9711479]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061760 |
   breast cancer type 2 susceptibility protein sequence variant Q1452* (human)
 |
   hBRCA2/var:Q1452*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-1451 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1451." [PRO:DNx, Reactome:R-HSA-9711427]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061763 |
   breast cancer type 2 susceptibility protein sequence variant G904* (human)
 |
   hBRCA2/var:G904*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-903 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-903." [PRO:DNx, Reactome:R-HSA-9711301]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061772 |
   breast cancer type 2 susceptibility protein sequence variant I1258* (human)
 |
   hBRCA2/var:I1258*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Pro-1257 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1257." [PRO:DNx, Reactome:R-HSA-9712124]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061793 |
   breast cancer type 2 susceptibility protein sequence variant S1099* (human)
 |
   hBRCA2/var:S1099*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-1098 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1098." [PRO:DNx, Reactome:R-HSA-9711289]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061829 |
   breast cancer type 2 susceptibility protein sequence variant K2392* (human)
 |
   hBRCA2/var:K2392*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-2391 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2391." [PRO:DNx, Reactome:R-HSA-9711511]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061844 |
   breast cancer type 2 susceptibility protein sequence variant V323* (human)
 |
   hBRCA2/var:V323*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-322 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-322." [PRO:DNx, Reactome:R-HSA-9712140]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061867 |
   breast cancer type 2 susceptibility protein sequence variant S2372* (human)
 |
   hBRCA2/var:S2372*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-2371 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2371." [PRO:DNx, Reactome:R-HSA-9711390]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061909 |
   breast cancer type 2 susceptibility protein sequence variant R2659T (human)
 |
   hBRCA2/var:R2659T
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Thr residue at the position equivalent to Arg-2659 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Arg-2659, CHEBI:30013." [PRO:DNx, Reactome:R-HSA-9763210]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061914 |
   breast cancer type 2 susceptibility protein sequence variant E866* (human)
 |
   hBRCA2/var:E866*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-865 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-865." [PRO:DNx, Reactome:R-HSA-9711156]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061921 |
   breast cancer type 2 susceptibility protein sequence variant E1717* (human)
 |
   hBRCA2/var:E1717*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-1716 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1716." [PRO:DNx, Reactome:R-HSA-9711401]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061926 |
   breast cancer type 2 susceptibility protein sequence variant Y2977* (human)
 |
   hBRCA2/var:Y2977*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-2976 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2976." [PRO:DNx, Reactome:R-HSA-9711182]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061932 |
   breast cancer type 2 susceptibility protein sequence variant E2474* (human)
 |
   hBRCA2/var:E2474*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Cys-2473 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2473." [PRO:DNx, Reactome:R-HSA-9711360]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061964 |
   breast cancer type 2 susceptibility protein sequence variant E1812* (human)
 |
   hBRCA2/var:E1812*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-1811 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1811." [PRO:DNx, Reactome:R-HSA-9711214]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000061987 |
   breast cancer type 2 susceptibility protein sequence variant Q1063* (human)
 |
   hBRCA2/var:Q1063*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Pro-1062 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1062." [PRO:DNx, Reactome:R-HSA-9711426]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062045 |
   breast cancer type 2 susceptibility protein sequence variant E1593* (human)
 |
   hBRCA2/var:E1593*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1592 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1592." [PRO:DNx, Reactome:R-HSA-9711570]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062063 |
   breast cancer type 2 susceptibility protein sequence variant K1649* (human)
 |
   hBRCA2/var:K1649*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ala-1648 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1648." [PRO:DNx, Reactome:R-HSA-9711305]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062082 |
   breast cancer type 2 susceptibility protein sequence variant E3111* (human)
 |
   hBRCA2/var:E3111*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-3110 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3110." [PRO:DNx, Reactome:R-HSA-9711162]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062110 |
   breast cancer type 2 susceptibility protein sequence variant L638* (human)
 |
   hBRCA2/var:L638*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-637 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-637." [PRO:DNx, Reactome:R-HSA-9711173]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062124 |
   breast cancer type 2 susceptibility protein sequence variant E409* (human)
 |
   hBRCA2/var:E409*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Met-408 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-408." [PRO:DNx, Reactome:R-HSA-9711271]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062133 |
   breast cancer type 2 susceptibility protein sequence variant E510* (human)
 |
   hBRCA2/var:E510*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Arg-509 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-509." [PRO:DNx, Reactome:R-HSA-9711449]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062147 |
   breast cancer type 2 susceptibility protein sequence variant G2837* (human)
 |
   hBRCA2/var:G2837*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-2836 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2836." [PRO:DNx, Reactome:R-HSA-9711302]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062152 |
   breast cancer type 2 susceptibility protein sequence variant S353* (human)
 |
   hBRCA2/var:S353*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-352 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-352." [PRO:DNx, Reactome:R-HSA-9711382]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062206 |
   breast cancer type 2 susceptibility protein sequence variant T2722R (human)
 |
   hBRCA2/var:T2722R
 |
  "A breast cancer type 2 susceptibility protein (human) that has an Arg residue at the position equivalent to Thr-2722 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Thr-2722, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9763214]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062240 |
   breast cancer type 2 susceptibility protein sequence variant Q754* (human)
 |
   hBRCA2/var:Q754*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Phe-753 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-753." [PRO:DNx, Reactome:R-HSA-9711473]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062314 |
   breast cancer type 2 susceptibility protein sequence variant L2375* (human)
 |
   hBRCA2/var:L2375*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-2374 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2374." [PRO:DNx, Reactome:R-HSA-9711559]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062320 |
   breast cancer type 2 susceptibility protein sequence variant W2586* (human)
 |
   hBRCA2/var:W2586*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-2585 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2585." [PRO:DNx, Reactome:R-HSA-9711487]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062322 |
   breast cancer type 2 susceptibility protein sequence variant D2723H (human)
 |
   hBRCA2/var:D2723H
 |
  "A breast cancer type 2 susceptibility protein (human) that has a His residue at the position equivalent to Asp-2723 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Asp-2723, CHEBI:29979." [PRO:DNx, Reactome:R-HSA-9763226]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062340 |
   breast cancer type 2 susceptibility protein sequence variant M2393* (human)
 |
   hBRCA2/var:M2393*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-2392 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2392." [PRO:DNx, Reactome:R-HSA-9712114]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062357 |
   breast cancer type 2 susceptibility protein sequence variant Q2024* (human)
 |
   hBRCA2/var:Q2024*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-2023 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2023." [PRO:DNx, Reactome:R-HSA-9711297]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062427 |
   breast cancer type 2 susceptibility protein sequence variant Q1429* (human)
 |
   hBRCA2/var:Q1429*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Phe-1428 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1428." [PRO:DNx, Reactome:R-HSA-9711422]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062479 |
   breast cancer type 2 susceptibility protein sequence variant M965* (human)
 |
   hBRCA2/var:M965*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-964 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-964." [PRO:DNx, Reactome:R-HSA-9712145]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062484 |
   breast cancer type 2 susceptibility protein sequence variant L1776* (human)
 |
   hBRCA2/var:L1776*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-1775 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1775." [PRO:DNx, Reactome:R-HSA-9712135]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062501 |
   breast cancer type 2 susceptibility protein sequence variant Q373* (human)
 |
   hBRCA2/var:Q373*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-372 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-372." [PRO:DNx, Reactome:R-HSA-9711586]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062546 |
   breast cancer type 2 susceptibility protein sequence variant E2956* (human)
 |
   hBRCA2/var:E2956*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ala-2955 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2955." [PRO:DNx, Reactome:R-HSA-9711532]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062558 |
   breast cancer type 2 susceptibility protein sequence variant R2625* (human)
 |
   hBRCA2/var:R2625*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-2624 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2624." [PRO:DNx, Reactome:R-HSA-9711482]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062573 |
   breast cancer type 2 susceptibility protein sequence variant S1271* (human)
 |
   hBRCA2/var:S1271*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-1270 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1270." [PRO:DNx, Reactome:R-HSA-9711197]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062574 |
   breast cancer type 2 susceptibility protein sequence variant Q3036* (human)
 |
   hBRCA2/var:Q3036*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-3035 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3035." [PRO:DNx, Reactome:R-HSA-9711281]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062635 |
   breast cancer type 2 susceptibility protein sequence variant E654* (human)
 |
   hBRCA2/var:E654*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-653 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-653." [PRO:DNx, Reactome:R-HSA-9711402]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062704 |
   breast cancer type 2 susceptibility protein sequence variant G2281* (human)
 |
   hBRCA2/var:G2281*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-2280 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2280." [PRO:DNx, Reactome:R-HSA-9711488]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062708 |
   breast cancer type 2 susceptibility protein sequence variant G25V (human)
 |
   hBRCA2/var:G25V
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Val residue at the position equivalent to Gly-25 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Gly-25, CHEBI:30015." [PRO:DNx, Reactome:R-HSA-9709629]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062756 |
   breast cancer type 2 susceptibility protein sequence variant T2722I (human)
 |
   hBRCA2/var:T2722I
 |
  "A breast cancer type 2 susceptibility protein (human) that has an Ile residue at the position equivalent to Thr-2722 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Thr-2722, CHEBI:30009." [PRO:DNx, Reactome:R-HSA-9763247]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062761 |
   breast cancer type 2 susceptibility protein sequence variant E1646* (human)
 |
   hBRCA2/var:E1646*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1645 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1645." [PRO:DNx, Reactome:R-HSA-9711377]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062820 |
   breast cancer type 2 susceptibility protein sequence variant E826* (human)
 |
   hBRCA2/var:E826*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-825 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-825." [PRO:DNx, Reactome:R-HSA-9711400]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062834 |
   breast cancer type 2 susceptibility protein sequence variant K1872* (human)
 |
   hBRCA2/var:K1872*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-1871 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1871." [PRO:DNx, Reactome:R-HSA-9711285]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062861 |
   breast cancer type 2 susceptibility protein sequence variant Q2870* (human)
 |
   hBRCA2/var:Q2870*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-2869 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2869." [PRO:DNx, Reactome:R-HSA-9711362]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062866 |
   breast cancer type 2 susceptibility protein sequence variant E2863* (human)
 |
   hBRCA2/var:E2863*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-2862 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2862." [PRO:DNx, Reactome:R-HSA-9711325]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062900 |
   breast cancer type 2 susceptibility protein sequence variant Y2884* (human)
 |
   hBRCA2/var:Y2884*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Pro-2883 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2883." [PRO:DNx, Reactome:R-HSA-9711266]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062904 |
   breast cancer type 2 susceptibility protein sequence variant S744* (human)
 |
   hBRCA2/var:S744*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to His-743 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-743." [PRO:DNx, Reactome:R-HSA-9711477]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062918 |
   breast cancer type 2 susceptibility protein sequence variant K2570* (human)
 |
   hBRCA2/var:K2570*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-2569 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2569." [PRO:DNx, Reactome:R-HSA-9711321]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062947 |
   breast cancer type 2 susceptibility protein sequence variant Q1987* (human)
 |
   hBRCA2/var:Q1987*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Val-1986 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1986." [PRO:DNx, Reactome:R-HSA-9711351]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062976 |
   breast cancer type 2 susceptibility protein sequence variant L2696* (human)
 |
   hBRCA2/var:L2696*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-2695 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2695." [PRO:DNx, Reactome:R-HSA-9711288]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062987 |
   breast cancer type 2 susceptibility protein sequence variant Y1894* (human)
 |
   hBRCA2/var:Y1894*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Cys-1893 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1893." [PRO:DNx, Reactome:R-HSA-9711218]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000062990 |
   breast cancer type 2 susceptibility protein sequence variant G1529R (human)
 |
   hBRCA2/var:G1529R
 |
  "A breast cancer type 2 susceptibility protein (human) that has an Arg residue at the position equivalent to Gly-1529 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Gly-1529, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9709587]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063010 |
   breast cancer type 2 susceptibility protein sequence variant E2959* (human)
 |
   hBRCA2/var:E2959*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-2958 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2958." [PRO:DNx, Reactome:R-HSA-9711554]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063042 |
   breast cancer type 2 susceptibility protein sequence variant S2695* (human)
 |
   hBRCA2/var:S2695*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-2694 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2694." [PRO:DNx, Reactome:R-HSA-9711376]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063067 |
   breast cancer type 2 susceptibility protein sequence variant E1285* (human)
 |
   hBRCA2/var:E1285*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-1284 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1284." [PRO:DNx, Reactome:R-HSA-9711249]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063072 |
   breast cancer type 2 susceptibility protein sequence variant G1006* (human)
 |
   hBRCA2/var:G1006*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Phe-1005 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1005." [PRO:DNx, Reactome:R-HSA-9711366]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063079 |
   breast cancer type 2 susceptibility protein sequence variant S3291A (human)
 |
   hBRCA2/var:S3291A
 |
  "A breast cancer type 2 susceptibility protein (human) that has an Ala residue at the position equivalent to Ser-3291 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Ser-3291, CHEBI:46217." [PRO:DNx, Reactome:R-HSA-9763126]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063108 |
   breast cancer type 2 susceptibility protein sequence variant L553* (human)
 |
   hBRCA2/var:L553*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-552 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-552." [PRO:DNx, Reactome:R-HSA-9711165]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063120 |
   breast cancer type 2 susceptibility protein sequence variant Q1124* (human)
 |
   hBRCA2/var:Q1124*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-1123 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1123." [PRO:DNx, Reactome:R-HSA-9711424]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063123 |
   breast cancer type 2 susceptibility protein sequence variant S2835* (human)
 |
   hBRCA2/var:S2835*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Thr-2834 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2834." [PRO:DNx, Reactome:R-HSA-9711345]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063206 |
   breast cancer type 2 susceptibility protein sequence variant R3128* (human)
 |
   hBRCA2/var:R3128*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Trp-3127 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3127." [PRO:DNx, Reactome:R-HSA-9711177]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063222 |
   breast cancer type 2 susceptibility protein sequence variant G2593* (human)
 |
   hBRCA2/var:G2593*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-2592 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2592." [PRO:DNx, Reactome:R-HSA-9711282]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063225 |
   breast cancer type 2 susceptibility protein sequence variant F1182* (human)
 |
   hBRCA2/var:F1182*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gln-1181 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1181." [PRO:DNx, Reactome:R-HSA-9712127]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063240 |
   breast cancer type 2 susceptibility protein sequence variant E3071* (human)
 |
   hBRCA2/var:E3071*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-3070 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3070." [PRO:DNx, Reactome:R-HSA-9711354]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063243 |
   breast cancer type 2 susceptibility protein sequence variant G25R (human)
 |
   hBRCA2/var:G25R
 |
  "A breast cancer type 2 susceptibility protein (human) that has an Arg residue at the position equivalent to Gly-25 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Gly-25, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9709627]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063256 |
   breast cancer type 2 susceptibility protein sequence variant R2520* (human)
 |
   hBRCA2/var:R2520*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Pro-2519 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2519." [PRO:DNx, Reactome:R-HSA-9711378]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063262 |
   breast cancer type 2 susceptibility protein sequence variant W31R (human)
 |
   hBRCA2/var:W31R
 |
  "A breast cancer type 2 susceptibility protein (human) that has an Arg residue at the position equivalent to Trp-31 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Trp-31, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9709628]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063272 |
   breast cancer type 2 susceptibility protein sequence variant E1276* (human)
 |
   hBRCA2/var:E1276*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-1275 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1275." [PRO:DNx, Reactome:R-HSA-9711430]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063289 |
   breast cancer type 2 susceptibility protein sequence variant E294* (human)
 |
   hBRCA2/var:E294*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-293 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-293." [PRO:DNx, Reactome:R-HSA-9711463]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063290 |
   breast cancer type 2 susceptibility protein sequence variant R2401* (human)
 |
   hBRCA2/var:R2401*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-2400 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2400." [PRO:DNx, Reactome:R-HSA-9711347]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063301 |
   breast cancer type 2 susceptibility protein sequence variant G561* (human)
 |
   hBRCA2/var:G561*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-560 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-560." [PRO:DNx, Reactome:R-HSA-9711148]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063320 |
   breast cancer type 2 susceptibility protein sequence variant E1581* (human)
 |
   hBRCA2/var:E1581*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Cys-1580 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1580." [PRO:DNx, Reactome:R-HSA-9711364]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063327 |
   breast cancer type 2 susceptibility protein sequence variant E2663V (human)
 |
   hBRCA2/var:E2663V
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Val residue at the position equivalent to Glu-2663 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Glu-2663, CHEBI:30015." [PRO:DNx, Reactome:R-HSA-9763216]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063385 |
   breast cancer type 2 susceptibility protein sequence variant E2129* (human)
 |
   hBRCA2/var:E2129*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-2128 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2128." [PRO:DNx, Reactome:R-HSA-9711221]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063387 |
   breast cancer type 2 susceptibility protein sequence variant G995* (human)
 |
   hBRCA2/var:G995*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ala-994 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-994." [PRO:DNx, Reactome:R-HSA-9711144]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063389 |
   breast cancer type 2 susceptibility protein sequence variant K604* (human)
 |
   hBRCA2/var:K604*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-603 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-603." [PRO:DNx, Reactome:R-HSA-9711257]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063404 |
   breast cancer type 2 susceptibility protein sequence variant E2476* (human)
 |
   hBRCA2/var:E2476*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-2475 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2475." [PRO:DNx, Reactome:R-HSA-9711393]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063407 |
   breast cancer type 2 susceptibility protein sequence variant Q1658* (human)
 |
   hBRCA2/var:Q1658*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-1657 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1657." [PRO:DNx, Reactome:R-HSA-9711519]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063423 |
   breast cancer type 2 susceptibility protein sequence variant E1113* (human)
 |
   hBRCA2/var:E1113*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Thr-1112 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1112." [PRO:DNx, Reactome:R-HSA-9711495]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063424 |
   breast cancer type 2 susceptibility protein sequence variant G2748D (human)
 |
   hBRCA2/var:G2748D
 |
  "A breast cancer type 2 susceptibility protein (human) that has an Asp residue at the position equivalent to Gly-2748 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Gly-2748, CHEBI:29958." [PRO:DNx, Reactome:R-HSA-9763219]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063448 |
   breast cancer type 2 susceptibility protein sequence variant W2626L (human)
 |
   hBRCA2/var:W2626L
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Leu residue at the position equivalent to Trp-2626 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Trp-2626, CHEBI:30006." [PRO:DNx, Reactome:R-HSA-9763253]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063456 |
   breast cancer type 2 susceptibility protein sequence variant Q2159* (human)
 |
   hBRCA2/var:Q2159*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Phe-2158 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2158." [PRO:DNx, Reactome:R-HSA-9711453]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063497 |
   breast cancer type 2 susceptibility protein sequence variant R2318* (human)
 |
   hBRCA2/var:R2318*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-2317 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2317." [PRO:DNx, Reactome:R-HSA-9711457]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063540 |
   breast cancer type 2 susceptibility protein sequence variant E897* (human)
 |
   hBRCA2/var:E897*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-896 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-896." [PRO:DNx, Reactome:R-HSA-9711170]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063561 |
   breast cancer type 2 susceptibility protein sequence variant E1518* (human)
 |
   hBRCA2/var:E1518*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1517 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1517." [PRO:DNx, Reactome:R-HSA-9711530]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063585 |
   breast cancer type 2 susceptibility protein sequence variant Q1551* (human)
 |
   hBRCA2/var:Q1551*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-1550 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1550." [PRO:DNx, Reactome:R-HSA-9711319]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063657 |
   breast cancer type 2 susceptibility protein sequence variant L105* (human)
 |
   hBRCA2/var:L105*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asp-104 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-104." [PRO:DNx, Reactome:R-HSA-9711370]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063667 |
   breast cancer type 2 susceptibility protein sequence variant E1555* (human)
 |
   hBRCA2/var:E1555*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-1554 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1554." [PRO:DNx, Reactome:R-HSA-9711309]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063673 |
   breast cancer type 2 susceptibility protein sequence variant Q2354* (human)
 |
   hBRCA2/var:Q2354*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-2353 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2353." [PRO:DNx, Reactome:R-HSA-9711203]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063689 |
   breast cancer type 2 susceptibility protein sequence variant S2978* (human)
 |
   hBRCA2/var:S2978*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Tyr-2977 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2977." [PRO:DNx, Reactome:R-HSA-9711261]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063713 |
   breast cancer type 2 susceptibility protein sequence variant G1122* (human)
 |
   hBRCA2/var:G1122*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-1121 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1121." [PRO:DNx, Reactome:R-HSA-9711224]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063737 |
   breast cancer type 2 susceptibility protein sequence variant K1453* (human)
 |
   hBRCA2/var:K1453*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gln-1452 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1452." [PRO:DNx, Reactome:R-HSA-9711571]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063759 |
   breast cancer type 2 susceptibility protein sequence variant E305* (human)
 |
   hBRCA2/var:E305*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-304 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-304." [PRO:DNx, Reactome:R-HSA-9711359]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063762 |
   breast cancer type 2 susceptibility protein sequence variant L1952* (human)
 |
   hBRCA2/var:L1952*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-1951 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1951." [PRO:DNx, Reactome:R-HSA-9711320]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063781 |
   breast cancer type 2 susceptibility protein sequence variant G4* (human)
 |
   hBRCA2/var:G4*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-3 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3." [PRO:DNx, Reactome:R-HSA-9711268]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063901 |
   breast cancer type 2 susceptibility protein sequence variant S1630* (human)
 |
   hBRCA2/var:S1630*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Thr-1629 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1629." [PRO:DNx, Reactome:R-HSA-9711199]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063952 |
   breast cancer type 2 susceptibility protein sequence variant S1882* (human)
 |
   hBRCA2/var:S1882*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1881 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1881." [PRO:DNx, Reactome:R-HSA-9711533]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000063961 |
   breast cancer type 2 susceptibility protein sequence variant Q2749* (human)
 |
   hBRCA2/var:Q2749*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Gly-2748 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2748." [PRO:DNx, Reactome:R-HSA-9711507]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064047 |
   breast cancer type 2 susceptibility protein sequence variant Q3026* (human)
 |
   hBRCA2/var:Q3026*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-3025 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3025." [PRO:DNx, Reactome:R-HSA-9711168]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064081 |
   breast cancer type 2 susceptibility protein sequence variant K467* (human)
 |
   hBRCA2/var:K467*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-466 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-466." [PRO:DNx, Reactome:R-HSA-9711243]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064088 |
   breast cancer type 2 susceptibility protein sequence variant E2599* (human)
 |
   hBRCA2/var:E2599*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Glu-2598 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2598." [PRO:DNx, Reactome:R-HSA-9711304]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064098 |
   breast cancer type 2 susceptibility protein sequence variant E1441* (human)
 |
   hBRCA2/var:E1441*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1440 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1440." [PRO:DNx, Reactome:R-HSA-9711558]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064128 |
   breast cancer type 2 susceptibility protein sequence variant E880* (human)
 |
   hBRCA2/var:E880*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-879 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-879." [PRO:DNx, Reactome:R-HSA-9711339]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064169 |
   breast cancer type 2 susceptibility protein sequence variant G106* (human)
 |
   hBRCA2/var:G106*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-105 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-105." [PRO:DNx, Reactome:R-HSA-9711255]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064172 |
   breast cancer type 2 susceptibility protein sequence variant V1862* (human)
 |
   hBRCA2/var:V1862*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-1861 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1861." [PRO:DNx, Reactome:R-HSA-9712112]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064320 |
   breast cancer type 2 susceptibility protein sequence variant K944* (human)
 |
   hBRCA2/var:K944*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ile-943 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-943." [PRO:DNx, Reactome:R-HSA-9711191]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064380 |
   breast cancer type 2 susceptibility protein sequence variant L2428* (human)
 |
   hBRCA2/var:L2428*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-2427 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2427." [PRO:DNx, Reactome:R-HSA-9711186]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064389 |
   breast cancer type 2 susceptibility protein sequence variant E2571* (human)
 |
   hBRCA2/var:E2571*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-2570 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2570." [PRO:DNx, Reactome:R-HSA-9711560]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064410 |
   breast cancer type 2 susceptibility protein sequence variant L659* (human)
 |
   hBRCA2/var:L659*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ser-658 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-658." [PRO:DNx, Reactome:R-HSA-9712151]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064420 |
   breast cancer type 2 susceptibility protein sequence variant E187* (human)
 |
   hBRCA2/var:E187*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ala-186 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-186." [PRO:DNx, Reactome:R-HSA-9711270]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064423 |
   breast cancer type 2 susceptibility protein sequence variant Q2731* (human)
 |
   hBRCA2/var:Q2731*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Ala-2730 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-2730." [PRO:DNx, Reactome:R-HSA-9711415]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064473 |
   breast cancer type 2 susceptibility protein sequence variant K178* (human)
 |
   hBRCA2/var:K178*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Pro-177 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-177." [PRO:DNx, Reactome:R-HSA-9711510]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064511 |
   breast cancer type 2 susceptibility protein sequence variant K3032* (human)
 |
   hBRCA2/var:K3032*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Lys-3031 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-3031." [PRO:DNx, Reactome:R-HSA-9711485]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064536 |
   breast cancer type 2 susceptibility protein sequence variant S1385* (human)
 |
   hBRCA2/var:S1385*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Leu-1384 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-1384." [PRO:DNx, Reactome:R-HSA-9711291]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064549 |
   breast cancer type 2 susceptibility protein sequence variant W31C (human)
 |
   hBRCA2/var:W31C
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Cys residue at the position equivalent to Trp-31 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Trp-31, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9709625]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064558 |
   breast cancer type 2 susceptibility protein sequence variant S648* (human)
 |
   hBRCA2/var:S648*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Cys-647 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-647." [PRO:DNx, Reactome:R-HSA-9711307]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064571 |
   breast cancer type 2 susceptibility protein sequence variant G405* (human)
 |
   hBRCA2/var:G405*
 |
  "A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Asn-404 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-404." [PRO:DNx, Reactome:R-HSA-9711250]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:000064582 |
   breast cancer type 2 susceptibility protein sequence variant D2723G (human)
 |
   hBRCA2/var:D2723G
 |
  "A breast cancer type 2 susceptibility protein (human) that has a Gly residue at the position equivalent to Asp-2723 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Asp-2723, CHEBI:29947." [PRO:DNx, Reactome:R-HSA-9763217]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000035486 |
   breast cancer type 2 susceptibility protein phosphorylated 1 (human)
 |
   hBRCA2/Phos:1
 |
  "A breast cancer type 2 susceptibility protein phosphorylated 1 in human." [PMID:10749118, PRO:KER]
 |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000045544 |
   breast cancer type 2 susceptibility protein phosphorylated 2 (human)
 |
   hBRCA2/Phos:2
 |
  "A breast cancer type 2 susceptibility protein (human) that has been phosphorylated on a Thr residue within the CT domain. UniProtKB:P51587, Thr-3387, MOD:00047." [PMID:18317453, PMID:24627786, PRO:CNA, PRO:QW]
 |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000045545 |
   breast cancer type 2 susceptibility protein unphosphorylated 2 (human)
 |
   hBRCA2/UnPhos:2
 |
  "A breast cancer type 2 susceptibility protein (human) that lacks phosphorylation on a Thr residue within the CT domain. UniProtKB:P51587, Thr-3387, PR:000026291." [PMID:18317453, PRO:CNA, PRO:QW]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000045817 |
   breast cancer type 2 susceptibility protein phosphorylated 3 (human)
 |
   hBRCA2/Phos:3
 |
  "A breast cancer type 2 susceptibility protein (human) that has been phosphorylated at Ser-3291. UniProtKB:P51587, Ser-3291, MOD:00046." [iPTMnet:P51587, PMID:15800615]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000066432 |
   breast cancer type 2 susceptibility protein deaminated 1 (human)
 |
   hBRCA2/Deam:1
 |
  "A breast cancer type 2 susceptibility protein (human) that has been deaminated on the residue at the position equivalent to Asn-1002 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Asn-1002, MOD:00684." [IEDB_epitope:837883, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000066492 |
   breast cancer type 2 susceptibility protein deaminated 2 (human)
 |
   hBRCA2/Deam:2
 |
  "A breast cancer type 2 susceptibility protein (human) that has been deaminated on the residue at the position equivalent to Gln-2354 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Gln-2354, MOD:00685." [IEDB_epitope:1355068, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000067955 |
   breast cancer type 2 susceptibility protein methylated 1 (human)
 |
   hBRCA2/Me:1
 |
  "A breast cancer type 2 susceptibility protein (human) that has been methylated on the residue at the position equivalent to Cys-1654 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Cys-1654, MOD:00660." [IEDB_epitope:1053235, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000070934 |
   breast cancer type 2 susceptibility protein methylated 2 (human)
 |
   hBRCA2/Me:2
 |
  "A breast cancer type 2 susceptibility protein (human) that has been methylated on the residue at the position equivalent to Cys-2126 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Cys-2126, MOD:00660." [IEDB_epitope:1026935, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000072027 |
   breast cancer type 2 susceptibility protein deaminated 3 (human)
 |
   hBRCA2/Deam:3
 |
  "A breast cancer type 2 susceptibility protein (human) that has been deaminated on the residue at the position equivalent to Asn-623 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Asn-623, MOD:00684." [IEDB_epitope:1366894, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000072752 |
   breast cancer type 2 susceptibility protein methylated 3 (human)
 |
   hBRCA2/Me:3
 |
  "A breast cancer type 2 susceptibility protein (human) that has been methylated on the residue at the position equivalent to Cys-480 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Cys-480, MOD:00660." [IEDB_epitope:1049157, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000073005 |
   breast cancer type 2 susceptibility protein deaminated 4 (human)
 |
   hBRCA2/Deam:4
 |
  "A breast cancer type 2 susceptibility protein (human) that has been deaminated on the residue at the position equivalent to Gln-1063 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Gln-1063, MOD:00685." [IEDB_epitope:1991874, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000075561 |
   breast cancer type 2 susceptibility protein phosphorylated 4 (human)
 |
   hBRCA2/Phos:4
 |
  "A breast cancer type 2 susceptibility protein (human) that has been phosphorylated on the residue at the position equivalent to Thr-167 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Thr-167, MOD:00047." [IEDB_epitope:1324597, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000078580 |
   breast cancer type 2 susceptibility protein cysteinylated 1 (human)
 |
   hBRCA2/Cyst:1
 |
  "A breast cancer type 2 susceptibility protein (human) that has been cysteinylated on the residue at the position equivalent to Cys-1654 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Cys-1654, MOD:00765." [IEDB_epitope:1589112, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000080574 |
   breast cancer type 2 susceptibility protein methylated 4 (human)
 |
   hBRCA2/Me:4
 |
  "A breast cancer type 2 susceptibility protein (human) that has been methylated on the residue at the position equivalent to Cys-1365 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, Cys-1365, MOD:00660." [IEDB_epitope:1013477, PRO:DNx]
 |

| 
|
|
|